Leafly
JANUARY 4, 2022
Gov. Wolf tweeted, "I just want to be sure we also include measures to restore justice to those who have been harmed by the War on Drugs.". The post Pennsylvania Gov tells lawmakers to stop stalling legalization, but will it help? appeared first on Leafly.
Cannabis Life Network
JANUARY 4, 2022
Christianity and weed — natural enemies or unusual bedfellows? Contrary to mainstream belief, cannabis has long enjoyed a place within religion and spirituality. The same goes for shamanic practices and the Rastafari religion, but what about Christianity? There is a general consensus that Christianity prohibits using most recreational psychoactive substances, including cannabis.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
JANUARY 4, 2022
A hemp grower that accused the police of destroying its crop has struggled to raise lawsuit funds. The grower’s law firm is launching a GoFundMe-style platform to crowdfund the money. Everyday investors would be able to earn money based on the outcome of lawsuits. Apothio, a hemp grower, is suing a California county whose deputies it’s accused of bulldozing $1 billion worth of its crops.
Veriheal
JANUARY 4, 2022
‘Spice’, or ‘K2’, is a substance often made up of synthetic cannabinoids. While we have already uncovered that this street drug is associated with serious health problems and adverse side effects , the largest study to date has just reinforced what we already know; Spice is far more harmful than cannabis. This large-scale study was published in Psychopharmacology.
Speaker: Jonathan Bench, International Cannabis and Securities Business Attorney at Harris Bricken
The U.S. cannabis industry is still in its infancy, even though states began engaging with legalization in one form or another in the late 1990s. Today, many opportunities exist for individuals and businesses that want to engage in the industry. Some want to directly own licensed businesses, while others prefer to keep the industry at an arm’s length and merely profit from it.
Canna Law Blog
JANUARY 4, 2022
The coming New Year heralded new administrative regulations for marijuana in the State of Oregon. These changes came through the Oregon Liquor and Cannabis Commission (OLCC) rulemaking process. That process, in turn, stems from cannabis laws passed by the Oregon legislature earlier this year. We gave a brief overview of the new rules last week. With the volume of changes, we expect to write a few posts analyzing those changes.
Medical Cannabis Brief brings together the best content for patients and advocates from the widest variety of industry thought leaders.
Cannabis Law Report
JANUARY 4, 2022
The California Department of Cannabis Control announced on Saturday that they are now accepting applications for fee waivers for equity licensees. To be eligible, businesses must have 50% equity applicant ownership and have, or expect to have, gross annual receipts of $1.5 million or less. Equity applicants in California must check at least one of the following: they were arrested for cannabis prior to November 8, 2016; their household income is less than or equal to 60% of the local median inc
TheAnswerPage
JANUARY 4, 2022
Other than pain sensation, is the endocannabinoid system involved in other CNS functions? Yes. CB1 receptors are located in several parts of the central nervous system including brain cortex, basal ganglia, cerebellum, hippocampus, ventral posterolateral thalamus, sensory neurons, dorsal root ganglia, and dorsal horn of spinal cord. These parts of the nervous system are involved in cognitive function, memory, behavior, emotion, and pain sensation.
Cannabis Law Report
JANUARY 4, 2022
Over $140 Million in Revenue Expected Over the First Three Years of Cultivation and Over $400 Million in Total Revenue Projected for the 10-Year Term of the Agreement. Expands Agrify’s Footprint to Lucrative and Fast-Growing Florida Cannabis Market. BILLERICA, Mass., January 4, 2022 – Agrify Corporation ( Nasdaq:AGFY ) (“Agrify” or the “Company”), the most innovative and vertically integrated provider of premium cultivation and extraction solutions for the cannabis and hemp industry, today annou
TheAnswerPage
JANUARY 4, 2022
Besides chronic pain, what are the common conditions for which patients use cannabinoid based medicines? According to a 2020 study, after unspecified chronic pain, patients were most likely to report anxiety as their primary medical condition, and anxiety was the most commonly reported comorbid condition. A 2016 study found that the second and third most common medical conditions for which patients reported using medical cannabis were anxiety (58.1%) and depression (50.3%).
Cannabis Law Report
JANUARY 4, 2022
At this particular moment in time, we’d be very happy if Sadiq Khan ran the entire planet. his combination of common sense, no-nonsense politics based around equity is sorely lacking elsewhere. The Guardian newspaper reports. Downing Street has expressed concern over moves to end the prosecution of young people caught with cannabis in some London boroughs, under a pilot scheme being developed by Sadiq Khan.
The Joint Blog
JANUARY 4, 2022
CBD is soaring in popularity, its ubiquity reflected in the various types and forms of merchandise that count the cannabinoid as its chief ingredient. Its popularity, of course, stems from its potential medical benefits, such as treating epilepsy, alleviating pain and inflammation, relieving anxiety, and others. . However, just because CBD has shown promise as a treatment for some disorders doesn’t mean it’s some miracle cure-all as some overeager marketers make it to be.
Cannabis Law Report
JANUARY 4, 2022
KTVH reports. Montana marijuana dispensaries made their first sales to adult-use customers on Saturday morning, Jan. 1, 2022. Most providers MTN talked to Tuesday said the first weekend was a success. An estimated 380 dispensaries in 29 counties are now able to sell marijuana to both medical and recreational customers. The Montana Department of Revenue reported that they recorded a combined $1,566,980 in marijuana sales on Saturday and Sunday.
Cannabis Law Report
JANUARY 4, 2022
Aurora Cannabis Inc. (the “ Company ” or “ Aurora “) (NASDAQ: ACB ) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the appointment of Chitwant Kohli to the Company’s Board of Directors (the “Board”), effective today. This is a newly added position that expands the Board to nine members, seven of whom are independent.
Cannabis Law Report
JANUARY 4, 2022
Here’s the official press release. Curaleaf Holdings, Inc. (CSE: CURA /OTCQX: CURLF ) (“Curaleaf” or the “Company”), a leading international provider of consumer products in cannabis, today announced that Matt Darin will become President of Curaleaf Holdings, Inc., effective immediately. Darin brings a wealth of industry knowledge and leadership experience at an important moment in Curaleaf’s growth trajectory; the company recently announced several strategic acquisitions in Los Suenos Fa
Cannabis Law Report
JANUARY 4, 2022
Here’s the announcement. We presume the F&B at their expos will now move up a notch ! This morning, we happily announced that MJBiz – including MJBizCon – has been acquired by Emerald X. Emerald is a major B2B event organizer in the U.S. They also put on shows like Outdoor Retailer, International Pizza Expo and ASD Market Week. Here’s what that means for MJBizCon.
Cannabis Law Report
JANUARY 4, 2022
AUSTIN, Texas–(BUSINESS WIRE)–Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication and substance abuse, has named Simon Allen as Chief Executive Officer and a member of the company’s Board of Directors, effective February 1 st , 2022.
Cannabis Law Report
JANUARY 4, 2022
MIAMI & TORONTO–(BUSINESS WIRE)–Flora Growth Corp. (NASDAQ: FLGC) (“Flora” or the “Company”), a leading all-outdoor cultivator and manufacturer of global cannabis products, announced today that its Mind Naturals skincare brand has launched sales through Walmart.com and Coppel, a nationwide department store in Mexico. The launch includes 12 products from the Mind Naturals portfolio, initially on e-commerce with subsequent plans to sell in brick and mortar retail locations.
Cannabis Law Report
JANUARY 4, 2022
~ Diversifies into Cannabis Industry for Immediate Expansion and Growth ~. NEW YORK–(BUSINESS WIRE)–Emerald Holding, Inc. (NYSE:EEX) (“Emerald” or the “Company”) today announced that it has completed the acquisition of MJBiz, the leading event producer and content platform serving the wide range of companies operating in the large and rapidly growing cannabis industry.
Cannabis Law Report
JANUARY 4, 2022
SAN DIEGO–(BUSINESS WIRE)– $INSD #businesscombination –Shareholder rights law firm Robbins LLP informs investors that a shareholder filed a class action on behalf of persons and entities that purchased or otherwise acquired Instadose Pharma Corp. (OTC: INSD) securities between December 8, 2020 and November 24, 2021, for violations of the Securities Exchange Act of 1934.
Cannabis Law Report
JANUARY 4, 2022
DUBLIN–(BUSINESS WIRE)–The “Australia Legal Cannabis Market Size, Share & Trends Analysis Report By Product Type (Marijuana, Hemp), By Application (Medical Use, Industrial Use), And Segment Forecasts, 2021 – 2028” report has been added to ResearchAndMarkets.com’s offering. The Australia legal cannabis market size is expected to reach USD 375.7 million by 2028, and is expected to expand at a CAGR of 32.7% from 2021 to 2028.
Cannabis Law Report
JANUARY 4, 2022
Cannabis Law Report
JANUARY 4, 2022
– Company Also Announces Intention to File Near-Term EUA Request with FDA for Linea 2.0 Assay and Recently Developed, Unsupervised, At-Home Sample Collection Kit to Expand Addressable Market and Scope of COVID-19 Testing Services – STONY BROOK, N.Y.–(BUSINESS WIRE)– $APDN #COVID19Testing — Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing and nucleic acid-based technologies, announced today
Cannabis Law Report
JANUARY 4, 2022
BERWYN, Pa.–(BUSINESS WIRE)– #pharma –Virpax ® Pharmaceuticals, Inc. (“Virpax”), a company specializing in product candidates for pain management, CNS disorders and anti-viral indications, today announced that it will be presenting virtually at the upcoming H.C. Wainwright event from Monday, January 10 th through Thursday, January 13 th starting at 7:00 a.m.
Cannabis Law Report
JANUARY 4, 2022
GREENWOOD VILLAGE, Colo. & LOS ANGELES–(BUSINESS WIRE)– ANANDA Scientific Inc., (a biotech pharma company) today announced approval by the U.S. Food and Drug Administration (FDA) of the Investigational New Drug (IND) application for the clinical trial evaluating Nantheia™ ATL5, an investigational drug using cannabidiol (CBD) in ANANDA’s proprietary delivery technology as an Adjunctive Treatment for Opioid Use Disorder.
Cannabis Law Report
JANUARY 4, 2022
BOSTON–(BUSINESS WIRE)– 908 Devices (NASDAQ: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biomolecular analysis, and the United States Forest Service (USFS), an agency of the United States Department of Agriculture (USDA), are collaborating on a research effort to extend the capabilities of the MX908 handheld device for rapid detection of toxic pesticides used in illegal marijuana grows on federal lands.
Cannabis Law Report
JANUARY 4, 2022
Marijuana Moment has this story of a booze happy senator who won’t vote to legalize medical cannabis because that might actually lead to adults smoking cannabis for their own pleasure…and we can’t be having that can we! Marijuana Moment reports. The reason for Thayer’s opposition is somewhat ironic. The senator said he thinks medical cannabis is “a slippery slope for recreational marijuana.
Cannabis Law Report
JANUARY 4, 2022
Ganjapreneur report. The U.S. arm of a pharmaceutical firm that last month announced an international partnership with an Israel-based medical cannabis company was found guilty by a Suffolk County, New York jury last week of contributing to the region’s opioid crisis, the Associated Press reports. In their verdict against Teva Pharmaceuticals USA Inc., the jury found the drug company played a role in the opioid crisis — which is legally called a public nuisance but contributed to more than 5
Expert insights. Personalized for you.
145 
Let's personalize your content